Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Depreciation & Amortization (CF) (2016 - 2025)

Ani Pharmaceuticals (ANIP) has disclosed Depreciation & Amortization (CF) for 16 consecutive years, with $22.6 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) changed 0.06% to $22.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $91.4 million through Dec 2025, up 34.97% year-over-year, with the annual reading at $91.4 million for FY2025, 34.97% up from the prior year.
  • Depreciation & Amortization (CF) hit $22.6 million in Q4 2025 for Ani Pharmaceuticals, roughly flat from $22.6 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $23.3 million in Q2 2025 to a low of $10.9 million in Q1 2021.
  • Historically, Depreciation & Amortization (CF) has averaged $16.3 million across 5 years, with a median of $14.7 million in 2023.
  • Biggest five-year swings in Depreciation & Amortization (CF): dropped 11.48% in 2023 and later soared 58.41% in 2025.
  • Year by year, Depreciation & Amortization (CF) stood at $13.7 million in 2021, then grew by 25.44% to $17.2 million in 2022, then dropped by 11.48% to $15.2 million in 2023, then skyrocketed by 48.74% to $22.6 million in 2024, then grew by 0.06% to $22.6 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for ANIP at $22.6 million in Q4 2025, $22.6 million in Q3 2025, and $23.3 million in Q2 2025.